Please assess the completion status of the following clinical trial:

Trial Title: ESP vs ESP With PECS

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Scheduled mitral valve replacement surgery~* obtained consent~Exclusion Criteria:~* allergy to oxycodone and local anesthetics~* depression, antidepressant drugs treatment~* epilepsy~* usage of painkiller before surgery~* addiction to alcohol or recreational drugs~* prolonged postoperative ventilation (over 2 hours)

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- ESP (Type: EXPERIMENTAL): Before the induction of general anesthesia, Erector Spinae Plane (ESP) blockade will be done. Postoperative analgesia is provided with intravenous oxycodone. Patient-controlled analgesia pump (PCA) will be used for this purpose.
- PECS (Type: EXPERIMENTAL): Before the induction of general anesthesia, Erector Spinae Plane (ESP) block and Pectoral fascia type I and II will be done. Postoperative analgesia is provided with intravenous oxycodone. Patient-controlled analgesia pump (PCA) will be used for this purpose.

Based on this trial design, predict the completion outcome and termination type (if applicable).